查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451896

认知和记忆增强药物市场报告（按产品（Aricept、Exelon、Namenda、Razadyne、Provigil、利他林、Adderall 等）、应用（疾病治疗、运动表现、学业成绩等）和地区 2024-2032 年

Cognitive and Memory Enhancer Drugs Market Report by Product (Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and Others), Application (Disease Treatment, Athletic Performance, Academic Performance, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球认知与记忆增强药物市场规模达到58.742亿美元。展望未来， IMARC Group预计到2032年市场规模将达到92.861亿美元，2024-2032年复合年增长率（CAGR）为5.06%。认知障碍的日益普及、探索新化合物和製剂的研发（R＆D）活动的​​增加以及新药物和创新递送方法的引入是推动市场的一些关键因素。

认知和记忆增强药物，也称为促智药物或智慧药物，旨在改善认知功能，如记忆、注意力、创造力和整体心理表现。这些药物旨在增强大脑活动并促进更好的认知能力。它们可以透过针对特定医疗状况的处方来获得，并且可以在柜檯 (OTC) 或线上购买作为膳食补充剂。它们透过增加大脑中某些神经传导物质的释放来增强警觉性和注意力。它们还能提高乙酰胆碱水平，这对记忆和学习很重要。它们可作为抗氧化剂或抗炎剂，保护大脑免受损伤并促进最佳的大脑功能。它们还可以促进更清晰的思维，提高认知处理速度，并带来更好的决策能力。它们有助于改善短期和长期记忆，从而更容易回忆和保留资讯。它们还透过提高生产力、效率和认知能力来帮助提高学业或工作表现。

认知与记忆增强药物市场趋势：

目前，阿兹海默症、失智症和注意力不足过动症（ADHD）等认知障碍的盛行率不断上升，是支持市场成长的关键因素之一。除此之外，人们越来越积极地关注大脑健康并寻求增强认知能力的方法，这刺激了对认知和记忆增强药物的需求。此外，增加研发（R＆D）活动以探索可以增强认知功能和记忆的新化合物和配方正在推动市场的成长。与此一致的是，新药和创新给药方法的开发正在扩大消费者的选择范围，从而加强市场的成长。此外，由于老年人口不断增加，对缓解与年龄相关的认知能力下降和记忆丧失的药物的需求不断增长，这提供了良好的市场前景。除此之外，寻求提高学术和专业表现的学生和专业人士越来越多地采用认知和记忆增强药物，这为行业投资者创造了利润丰厚的成长机会。此外，认知和记忆增强药物透过线上和线下分销管道的广泛使用正在加强市场的成长。

本报告回答的关键问题：

  • 迄今为止，全球认知和记忆增强药物市场表现如何，未来几年将如何表现？
  • 全球认知和记忆增强药物市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球认知和记忆增强药物市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的认知和记忆增强药物市场？
  • 基于产品的市场区隔是什么？
  • 认知和记忆增强药物市场上最具吸引力的产品是什么？
  • 基于应用程式的市场区隔是什么？
  • 认知和记忆增强药物市场中最有吸引力的应用是什么？
  • 全球认知与记忆增强药物市场的竞争结构如何？
  • 全球认知和记忆增强药物市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球认知与记忆增强药物市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 安理申
    • 市场走向
    • 市场预测
  • 艾克赛隆
    • 市场走向
    • 市场预测
  • 纳门达
    • 市场走向
    • 市场预测
  • 拉札迪因
    • 市场走向
    • 市场预测
  • 普罗维登斯
    • 市场走向
    • 市场预测
  • 利他能
    • 市场走向
    • 市场预测
  • 阿得拉
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按应用

  • 疾病治疗
    • 市场走向
    • 市场预测
  • 运动表现
    • 市场走向
    • 市场预测
  • 学业成绩
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 9 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AbbVie Inc.
    • Biogen Inc.
    • Eisai Co Ltd.
    • Novartis AG
    • Takeda Pharmaceutical Company Ltd.
Product Code: SR112024A8341

The global cognitive and memory enhancer drugs market size reached US$ 5,874.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 9,286.1 Million by 2032, exhibiting a growth rate (CAGR) of 5.06% during 2024-2032. The growing prevalence of cognitive disorders, increasing research and development (R&D) activities to explore new compounds and formulations, and introduction of novel drugs and innovative delivery methods represent some of the key factors driving the market.

Cognitive and memory enhancer drugs, also known as nootropics or smart drugs, aim to improve cognitive function like memory, attention, creativity, and overall mental performance. These drugs are designed to enhance brain activity and promote better cognitive abilities. They are available by prescription for specific medical conditions and can be purchased over the counter (OTC) or online as dietary supplements. They enhance alertness and focus by increasing the release of certain neurotransmitters in the brain. They also boost acetylcholine levels, which is important for memory and learning. They act as antioxidants or anti-inflammatory agents, protecting the brain from damage and promoting optimal brain function. They can also promote clearer thinking and improve cognitive processing speed and lead to better decision-making abilities. They assist in improving short-term and long-term memory, which makes it easier to recall and retain information. They also aid in enhancing academic or work performance by increasing productivity, efficiency, and cognitive abilities.

Cognitive and Memory Enhancer Drugs Market Trends:

At present, the rising prevalence of cognitive disorders, such as Alzheimer's disease, dementia, and attention deficit hyperactivity disorder (ADHD), represents one of the key factors supporting the growth of the market. Besides this, people are becoming more proactive in taking care of their brain health and seeking ways to enhance their cognitive abilities, which is catalyzing the demand for cognitive and memory enhancer drugs. Moreover, increasing research and development (R&D) activities to explore new compounds and formulations that can enhance cognitive functions and memory is propelling the growth of the market. In line with this, the development of novel drugs and innovative delivery methods is expanding the range of options available to consumers, which is strengthening the growth of the market. In addition, the growing demand for drugs that can alleviate age-related cognitive decline and memory loss due to the rising elderly population is offering a favorable market outlook. Apart from this, the increasing adoption of cognitive and memory enhancer drugs among students and professionals seeking improved academic and professional performance is creating lucrative growth opportunities for industry investors. Additionally, the wide availability of cognitive and memory enhancer drugs through online and offline distribution channels is strengthening the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cognitive and memory enhancer drugs market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product and application.

Product Insights:

Aricept

Exelon

Namenda

Razadyne

Provigil

Ritalin

Adderall

Others

The report has provided a detailed breakup and analysis of the cognitive and memory enhancer drugs market based on the type. This includes Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and others. According to the report, Aricept represented the largest segment.

Application Insights:

Disease Treatment

Athletic Performance

Academic Performance

Others

A detailed breakup and analysis of the cognitive and memory enhancer drugs market based on the application has also been provided in the report. This includes disease treatment, athletic performance, academic performance, and others. According to the report, disease treatment accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cognitive and memory enhancer drugs. Some of the factors driving the North America cognitive and memory enhancer drugs market included the growing elderly population, increasing need to enhance focus, memory, and overall cognitive abilities, development of novel drugs, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global cognitive and memory enhancer drugs market. Detailed profiles of all major companies have been provided. Some of the companies covered include AbbVie Inc., Biogen Inc., Eisai Co Ltd., Novartis AG, Takeda Pharmaceutical Company Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global cognitive and memory enhancer drugs market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global cognitive and memory enhancer drugs market?
  • What is the impact of each driver, restraint, and opportunity on the global cognitive and memory enhancer drugs market?
  • What are the key regional markets?
  • Which countries represent the most attractive cognitive and memory enhancer drugs market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the cognitive and memory enhancer drugs market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the cognitive and memory enhancer drugs market?
  • What is the competitive structure of the global cognitive and memory enhancer drugs market?
  • Who are the key players/companies in the global cognitive and memory enhancer drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cognitive and Memory Enhancer Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Aricept
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Exelon
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Namenda
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Razadyne
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Provigil
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Ritalin
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Adderall
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Disease Treatment
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Athletic Performance
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Academic Performance
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 AbbVie Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Biogen Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Eisai Co Ltd.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Novartis AG
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Takeda Pharmaceutical Company Ltd.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Cognitive and Memory Enhancer Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Cognitive and Memory Enhancer Drugs Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Cognitive and Memory Enhancer Drugs Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Cognitive and Memory Enhancer Drugs Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Cognitive and Memory Enhancer Drugs (Aricept) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Cognitive and Memory Enhancer Drugs (Aricept) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Cognitive and Memory Enhancer Drugs (Exelon) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Cognitive and Memory Enhancer Drugs (Exelon) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Cognitive and Memory Enhancer Drugs (Namenda) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Cognitive and Memory Enhancer Drugs (Namenda) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Cognitive and Memory Enhancer Drugs (Razadyne) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Cognitive and Memory Enhancer Drugs (Razadyne) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Cognitive and Memory Enhancer Drugs (Provigil) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Cognitive and Memory Enhancer Drugs (Provigil) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Cognitive and Memory Enhancer Drugs (Ritalin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Cognitive and Memory Enhancer Drugs (Ritalin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Cognitive and Memory Enhancer Drugs (Adderall) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Cognitive and Memory Enhancer Drugs (Adderall) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Cognitive and Memory Enhancer Drugs (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Cognitive and Memory Enhancer Drugs (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Cognitive and Memory Enhancer Drugs (Disease Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Cognitive and Memory Enhancer Drugs (Disease Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Cognitive and Memory Enhancer Drugs (Athletic Performance) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Cognitive and Memory Enhancer Drugs (Athletic Performance) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Cognitive and Memory Enhancer Drugs (Academic Performance) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Cognitive and Memory Enhancer Drugs (Academic Performance) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Cognitive and Memory Enhancer Drugs (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Cognitive and Memory Enhancer Drugs (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: North America: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: North America: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: United States: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Canada: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Canada: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Asia-Pacific: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Asia-Pacific: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: China: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Japan: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Japan: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: India: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: India: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: South Korea: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: South Korea: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Australia: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Australia: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Indonesia: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Indonesia: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Europe: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Europe: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Germany: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: France: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: France: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United Kingdom: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United Kingdom: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Italy: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Italy: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Spain: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Spain: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Russia: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Russia: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Latin America: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Latin America: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Brazil: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Mexico: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Mexico: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Middle East and Africa: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Middle East and Africa: Cognitive and Memory Enhancer Drugs Market: Breakup by Country (in %), 2023
  • Figure 79: Middle East and Africa: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Global: Cognitive and Memory Enhancer Drugs Industry: Drivers, Restraints, and Opportunities
  • Figure 81: Global: Cognitive and Memory Enhancer Drugs Industry: Value Chain Analysis
  • Figure 82: Global: Cognitive and Memory Enhancer Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cognitive and Memory Enhancer Drugs Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Cognitive and Memory Enhancer Drugs Market: Competitive Structure
  • Table 6: Global: Cognitive and Memory Enhancer Drugs Market: Key Players